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The Spectrin-Ankyrin Skeleton Controls CD45
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stability of many surface proteins and also participates
in the organization and dynamics of internal membrane
compartments, including the Golgi, endosomes, and
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acidic phospholipid axonal vesicles, and with vesicularand Developmental Biology
traffic in the secretory pathway (Beck and Nelson, 1998;Yale University
De Matteis and Morrow, 2000; Muresan et al., 2001). At310 Cedar Street
least two regions of  spectrin mediate its associationNew Haven, Connecticut 06510
with organelles: (1) an NH2-terminal region that includes
a direct membrane association domain (MAD1) and an
actin and ARP1 binding domain; and (2) a region nearSummary
the COOH terminus that includes a pleckstrin homology
(PH) domain that binds directly to acidic phospholipidsWith T cell receptor stimulation, intracellular pools of
such as membrane phosphatidylinositol 4,5-bisphos-CD45 and spectrin move to the surface. These pro-
phate (PtdInsP2) (De Matteis and Morrow, 2000). Linkagecesses are coupled. In both peripheral lymphocytes
to integral membrane proteins is mediated predomi-and Jurkat T cells, I spectrin and ankyrin associate
nantly by ankyrin, which also binds to  spectrin’s 14–with CD45. In Jurkat T cells, I spectrin peptides sup-
15th repeat region. Multiple isoforms of spectrin exist,press surface recruitment of CD45 and CD3 and abro-
generated by seven distinct genes and by extensivegate T cell activation. Other glycoproteins such as
alternative mRNA splicing (De Matteis and Morrow,CD43 are not altered by the spectrin peptides. Spec-
2000). I spectrin has been definitively identified only intrin’s effects are mediated by ankyrin, which binds
erythrocytes, brain, and muscle, although immunocross-directly to the cytoplasmic domain of CD45 (Kd  4.3
reactive forms have been found in the Golgi of other3.0 nM). These data reveal a novel and unexpected
cells. II spectrin is widely expressed and generally as-contribution of the spectrin-ankyrin skeleton to the
sociated with the plasma membrane (PM). III spectrincontrol of T lymphocyte function.
associates with both the PM as well as with the Golgi
in neurons and epithelial cells, and with actively trans-Introduction
ported vesicles in the secretory and endocytic pathways
(Holleran et al., 2001; Muresan et al., 2001; SakaguchiCD45 is a membrane phosphotyrosine phosphatase ex-
et al., 1998; Stankewich et al., 1998). IV and V spectrinpressed in cells of hematopoietic lineage. Its genetic
are specialized forms with more restricted tissue distri-deletion causes defective thymocyte development and
butions. Under most conditions,  spectrins join withfailed receptor-mediated activation (Wallace et al.,
an -spectrin to form an  heterodimer. I spectrin is1997), while defects in CD45 underlie human forms of
found predominantly in red cells; II spectrin is widelysevere combined immunodeficiency (Buckley, 2001).
distributed in most other cells.Proximity of CD45 to the T cell receptor (TCR) is neces-
Lymphocytes contain, in addition to PM-associatedsary for activation (Turka et al., 1992), but the mechanism
spectrin, an unusual cytoplasmic skeleton composed ofby which CD45 modulates TCR function remains a topic
a spectrin-ankyrin-rich perinuclear vesicular aggregateof interest and controversy (Alexander, 2000; Leitenberg
(Black et al., 1988). This complex is variably present inet al., 2001). Available data suggest that CD45 may prime
both cultured and native lymphocytes (Gregorio et al.,the src family tyrosine kinases required for TCR signaling
1994; Pauly et al., 1986), is regulated in part by Ca2
by removing an inhibitory phosphate (Ledbetter et al.,
and PKC (Gregorio et al., 1993, 1992), and is recruited
1993), an action requiring the formation of macromolec-
to the PM coincident with cell activation (Gregorio et al.,
ular protein complexes on the membrane that include 1992; Masso-Welch et al., 1999). However, the precise
CD45, the TCR, and other costimulatory molecules (Ishii composition or role of this spectrin-ankyrin-rich organ-
et al., 2001; Turka et al., 1992). Spatial segregation be- elle remains uncertain. Given the newly recognized as-
tween CD45 and other receptors may also be effected sociation of spectrin with both Golgi and endosomal
by its exclusion from detergent insoluble glycolipid (DIG) compartments, it seems likely that this perinuclear ag-
rafts (Janes et al., 1999), sphingomyelin-enriched clus- gregate in lymphocytes represents a modified and ex-
ters harboring the TCR. While many details remain to panded trans-Golgi network (TGN) or a late endosomal
be clarified, these observations suggest that key deter- compartment, presumably containing nascent or recy-
minants of the functional activity of CD45 and its rela- cled membrane constituents poised for recruitment to
tionship to the TCR include processes that control the the membrane upon cell activation. In either case, these
surface display and surface partitioning of CD45 be- early observations point to a role for spectrin and ankyrin
tween laterally organized microdomains. in the biogenesis of the lymphocyte membrane and its
In vertebrate cells, an extensive membrane-associ- response to TCR stimulation.
ated spectrin-ankyrin scaffold tethers membrane and In the present study, we have evaluated spectrin’s
cytosolic proteins to the actin and microtubule cytoskel- composition, distribution, and function in lymphocytes
eton. This skeleton controls the lateral organization and and its relationship to T cell function and CD45 dynam-
ics. We identify two spectrins not previously observed
in lymphocytes and demonstrate that I spectrin, acting1Correspondence: jon.morrow@yale.edu
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Figure 1. Primary Lymphocytes Express Multiple Spectrins that Associate with CD45
(A) Flow cytometry of fresh purified human PBLs was composed of CD45-positive lymphocytes (72%), with minor contamination by monocytes
(10%). Dead cells and cellular debris comprised less than 10% of the preparation. Western blot analysis of the CD45-enriched lymphocyte
fraction revealed I, II, and III spectrin isoforms. A faint secondary band at 276 kDa (*) represents the I2 isoform. RT-PCR analysis
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with ankyrin, facilitates the movement of CD45 and CD3 I spectrin displayed a largely cytoplasmic and patchy
surface distribution and was the spectrin most oftento the lymphocyte surface. Disruption of this process
abrogates the ability of T cells to be activated. These accumulated in protruding surface blebs visible on many
of the lymphocytes (Figure 1B, arrows). This spectrinfindings reveal a role for spectrin and ankyrin in the
signal transduction pathways of T lymphocytes and sug- also appeared to concentrate in cytoplasmic aggre-
gates, presumably near the nucleus, in a pattern similargest novel mechanisms by which the display and sur-
face partitioning of key lymphocyte receptors and co- to that previously observed in lymphocytes with avian
spectrin antibodies (Black et al., 1988). Antibodies spe-stimulatory molecules can be regulated.
cific for either of two alternative transcripts of I spec-
trin, termed I1 and I2, as well as antibodies thatResults
were pan-reactive to all I isoforms, gave indistinguish-
able results, suggesting the presence of both I1 andCD45 Associates with Spectrin and Ankyrin
in Peripheral Blood Lymphocytes I2 spectrin in these cells. The pattern for III spectrin
was similar to that observed in epithelial cells (Stanke-Independent studies have detected spectrin at the
membrane and in cytoplasmic aggregates of lympho- wich et al., 1998), in that it stained coarse cytoplasmic
vesicles, with a putative juxtanuclear concentration,cytes, and have shown that CD45 can bind directly to
spectrin in vitro (Lokeshwar and Bourguignon, 1992). To along with focal areas of the surface membrane (Figure
1B, double arrows). Finally, because of the strong asso-understand whether CD45 binds to the spectrin and
ankyrin skeleton in vivo, a CD45-rich, monocyte-depleted ciation between CD45 and I spectrin detected by im-
munoprecipitation, their distribution was examined bypopulation of fresh human peripheral blood leukocytes
(PBL) were evaluated by immunoprecipitation and West- double indirect immunofluorescence (Figure 1B, bottom
panel). Substantial (although not complete) overlap ofern blotting with anti-CD45 or with antibodies specific
for the different spectrins (Figure 1A). The antibody to these proteins was noted, particularly in surface blebs,
polarized surface patches, and within intracellular accu-CD45 revealed bands in Western blots ranging from 220
to 180 kDa. The CD45 and I spectrin precipitates were mulations.
rich in ankyrin, indicating that ankyrin was part of the
CD45-spectrin complex. Antibodies to each of the spec- I Spectrin Codistributes with CD45
in Jurkat T Cellstrins also precipitated CD45, suggesting the presence
of two novel spectrins (I and III) previously unrecog- The human Jurkat T lymphocyte line offers an experi-
mentally accessible system useful for the evaluation ofnized in lymphocytes, and the broad association of
CD45 with several spectrin compartments. The pres- spectrin perturbation on the dynamics of CD45 traffick-
ing. Immunofluorescent and Western blot analysis con-ence of I and III spectrin in PBLs was directly con-
firmed by Western blot and by RT-PCR (Figure 1A, right firmed in this line the same complex profile of spectrin
isoforms as in PBLs (Figure 2A). In Jurkat cells, both IIpanels). Ankyrin was relatively enriched in the CD45/I
spectrin compartment versus the other spectrin precipi- and II spectrin associated predominantly with the PM,
often concentrating on surface folds, a pattern similartates.
Given the surprising finding of multiple spectrin iso- to that observed in PBLs. I spectrin was found in the
cytoplasm, in dense perinuclear aggregates, and in po-forms in PBLs, it was of interest to determine their intra-
cellular disposition. Indirect immunofluorescence re- larized surface patches and surface blebs on the PM
(also Figure 2B). Again, this pattern was reminiscent ofvealed for each spectrin a somewhat variable and
overlapping, but distinctive distribution (Figure 1B). II that observed in PBLs. III spectrin was usually present
as coarse cytoplasmic punctate structures concen-spectrin was uniformly distributed on the PM, as is typi-
cal of other cells; small cytoplasmic accumulations were trated over the putative Golgi region; in some cells, it
was also concentrated into small dense surface blebs,also evident, presumably due to its association with
the different  spectrins. II spectrin also displayed a like the occasional small III spectrin blebs observed in
PBLs. Ankyrin G119 (AnkG119), a short form of ankyrinsurface membrane distribution, albeit less pronounced
than withII spectrin. In other cells, it was found concen- associated with the Golgi (Devarajan et al., 1996), dis-
played a pattern similar to III spectrin. Ankyrin R wastrated in relatively large surface patches near one end
of the cell, similar to the variable and polarized spectrin present on the PM and often polarized in dense mem-
brane patches. Western blot analysis confirmed thedistribution noted in earlier studies, and occasionally but
not consistently was faintly present on surface blebs. presence of these proteins at their expected sizes. Two
confirmed the presence of both I and III transcripts in PBLs. (Inset) The association of CD45 with elements of the spectrin-ankyrin cytoskeleton
was assayed by immunoprecipitation. Antibodies to each of four spectrins (I, II/II, III) efficiently coimmunoprecipitated CD45. Antibodies
to CD45 also coprecipitated a high-molecular weight ankyrin (Mr  215 kDa) that was reactive with AnkR antibodies. This same ankyrin was
equally well precipitated by I spectrin antibodies and to a lesser degree by IIII and III spectrin antibodies.
(B) Indirect immunofluorescent analysis of human PBLs demonstrated overlapping but distinct patterns of spectrin staining for each of the
spectrin isoforms. II spectrin was most abundant on the PM. II spectrin was present on surface folds of the PM and was often concentrated
in relatively large surface patches. I spectrin displayed a cytoplasmic and patchy surface distribution and was the spectrin most often
accumulated into the protruding surface blebs visible on many of the lymphocytes (arrows). This pattern was similar whether antibodies to
I1 or I2 were used (I2 results shown). Spectrin I also appeared to concentrate in an aggregate near the nucleus, in a pattern similar
to that previously observed in lymphocytes with avian spectrin antibodies (see text). III spectrin displayed a coarse vesicular cytoplasmic
pattern with focal areas of intense surface membrane staining (double arrows).
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I spectrin bands (Mr 220 and 276 kDa) were ob- expressed each construct with fidelity as measured by
RT-PCR (Figure 3, top), and in approximately equal pro-served, corresponding to the I1 and I2 isoforms
as confirmed by RT-PCR (Figure 2A, inset). The smaller tein amounts as measured by flow cytometry in per-
meabilized cells with antibodies specific to the FLAGbands in each lane presumably represented minor deg-
radation products. The cellular distribution of the spec- epitope (Figure 3). Immunofluorescent microscopy re-
vealed a marked loss of surface CD45, particularly intrins was then compared with CD45 using deconvolution
microscopy (Figure 2B). At the PM, CD45 was often the surface blebs, for cells expressing IN-5 and I14-15.
These cells also appeared to accumulate increased cy-concentrated into surface patches and surface blebs
(Figure 2B, arrows). Occasional internal pools of CD45 tosolic concentrations of CD45 as dense cytosolic ag-
gregates (Figure 3). Conversely, in cells expressingin a juxtanuclear position were also noted (Figure 2B, *).
Spectrin I was the predominant isoform codistributed IN-5,15 the surface display of CD45 approximated normal
levels, and many cells even appeared to have a superwith the surface patches and blebs of CD45.
abundance of CD45-positive surface patches and blebs
(Figure 3). No significant changes in the endogenousI Spectrin Peptides Disrupt the Surface
spectrin distributions in these cells were detected.Display of CD45
The surface levels of CD45 were also assessed byTo better understand the relationship between I spec-
FACS analysis (Figure 4). These results paralleled thetrin and CD45 organization, Jurkat cells were trans-
immunofluorescent observations and confirmed that thefected with I spectrin constructs encoding specific
IN-5 and I14-15 spectrin peptides reduced surface levelsfunctional domains. Three peptides were studied. Given
of CD45 by over a log, while the IN-5,15 peptide wasthe coprecipitation of CD45 with spectrin and ankyrin,
without significant effect. Western blots revealed no sig-as well as the sensitivity of lymphocyte activation to
nificant change in total cellular CD45, regardless of theagents that disrupt or modify the actin skeleton (Dustin
spectrin peptide expressed (Figure 4B), indicating thatand Cooper, 2000), the two functional domains of great-
the I spectrin peptides affected only the surface distri-est interest were the actin/ARP1 binding domain (ABD)
bution and surface display of CD45 but not its net rateand the ankyrin binding domain (Figure 3). In earlier
of synthesis, degradation, or shedding from the surface.work, transfection of a I spectrin peptide (IN-5) encom-
Similar experiments were also carried out with trans-passing the ABD into epithelial cells led to dominant
fected III spectrin constructs (Figure 4A). While thesuppression of the transport of -Na,K-ATPase through
spectrins are a closely related gene family, considerablethe secretory pathway (Devarajan et al., 1997). A second
sequence divergence exists within this family, presum-peptide chosen for study was I14-15, which encom-
ably accounting for their often unique intracellular distri-passes the ankyrin binding domain in repeats 14–15.
butions and functions. Pertinent to the present study,The IN-5 peptide will bind actin and dynein/dynactin
the degree of sequence homology (I versus III) was:complexes but will not support ankyrin-dependent link-
N-5, 61.5%; 14-15, 54%; N-5,15, 55.0%. Within just theages between membrane proteins and spectrin. The
ankyrin binding domain (repeat 15), the homology be-I14-15 peptide will compete with endogenous spectrin
tween I and III spectrin drops to 41.5%. Thus, thesefor ankyrin-dependent binding to membrane proteins
proteins are substantially different. Accordingly, evenbut will not couple these proteins to other cytoskeletal
though III spectrin partially colocalized and coprecipi-elements such as actin, dynein/dynactin, or to other
tated with CD45 (although it bound little ankyrin, Figurespectrins. A third peptide was also prepared, IN-5,15,
1), it had little effect on the surface abundance of CD45that included the ABD and ankyrin binding domain, but
(Figure 4). Thus, the inhibitory effects of these peptidesdeleted spectrin’s other functions, including the binding
on CD45 surface display appeared to be specific for Iof membrane phosphatidylinositol phospholipids via its
spectrin constructs.PH domain (Godi et al., 1998).
At least five stable independent cell lines were estab-
lished for each construct. All gave comparable results. I Spectrin Peptides Reduce Surface CD3 but Not
Surface CD43 and Block T Cell ActivationOnly low levels of stable I spectrin peptide expression
could be achieved, presumably because higher levels The impact of the transfected I spectrin peptides on
the surface display of other selected receptors was alsowere cytotoxic. The stable lines that were established
Figure 2. I Spectrin Codistributes with CD45 in Jurkat T Cells
(A) Jurkat T cells were examined by indirect immunofluorescence for the presence of different spectrins. II and II spectrin were found
predominantly on the PM. I spectrin was present as perinuclear cytoplasmic aggregates or on surface blebs (also see [B]). III spectrin
usually displayed a coarse punctate perinuclear distribution, as did AnkG119. Occasional cells also displayed small intense III spectrin-enriched
knobs on their surface, very similar to a pattern occasionally observed in PBLs. AnkR displayed a distribution similar to I spectrin and was
also present on the PM, often in polarized surface patches. Western blots again confirmed the presence of each of the spectrins. Note the
presence of two large I reactive bands, indicative of I1 (220 kDa) and I2 (276 kDa). RT-PCR analysis confirmed that both I1 and
I2 transcripts were expressed.
(B) Deconvolution immunofluorescent microscopy of CD45 (red), spectrin (green), and their relationship to the nucleus (stained with DAPI,
blue). Each deconvoluted image represents an 1 m slice though the cell. CD45 codistributes predominantly in surface blebs (arrows) with
I spectrin, as indicated by the areas of overlapping fluorescence (yellow). There is less association of CD45 with III spectrin, and essentially
no codistribution with II or II spectrin. Also apparent in some cells is a tight peri-nuclear concentration of CD45 (marked with an *). The
right-most column represents a collage of cells presented at higher magnification (note scale). Negligible immunofluorescence was noted
with preimmune serum (NRS).
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Figure 3. Transfection of I Spectrin Peptides into Jurkat Cells
(Top) Cartoon depicting the relationship of the peptides encoded by the three I constructs to I spectrin. The loci of the actin/ARP1 binding
domain near the NH2 terminus, the MAD1 membrane binding region in repeat 1, and the ankyrin binding domain in repeats 14–15 are depicted.
All constructs encoded a FLAG epitope tag at the NH2 terminus to enable their detection in transfected cells. Analysis by RT-PCR of each
cell line confirmed the expression of the appropriate construct. The cell lines analyzed in each lane were: lane 1, vector; lane 2, IN-5; lane 3,
I14-15; lane 4, IN-5,15; lane 5, wt cells; lane 6, markers. Note that in each case, primers were chosen that required the presence of both FLAG
sequence and the appropriate I spectrin sequence.
(Bottom) Impact of the transfected peptides on the surface distribution of CD45 (red). Also shown is the distribution of II spectrin (green),
along with a merged image for each transfected cell line. All stable Jurkat lines expressed similar levels of transfected construct, as measured
by flow cytometry (FLAG, right panel). Note that in cells expressing IN-5 or I14-15, there is a reduction in the quantity and intensity of CD45
associated with the surface membrane, and especially with surface membrane blebs, compared to wild-type cells (Figure 2). These cells also
appear to accumulate increased cytosolic concentrations of CD45, appearing as dense perinuclear cytosolic aggregates (*). Conversely, in
cells transfected with IN-5,15 there is enhanced abundance of CD45 associated with the surface and with surface membrane blebs.
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Figure 4. Spectrin Peptides Suppress the Display of Only a Subset of Membrane Proteins
(A) Flow cytometry reveals suppression of surface CD45 and CD3 in Jurkat cells expressing the IN-5 and I14-15 constructs. These constructs
have no effect on the surface display of CD43, a membrane glycoprotein linked to the cortical actin skeleton by moesin (Allenspach et al.,
2001). Similar constructs derived from III spectrin (labeled here with GFP) do not suppress CD45. (Separate experiments have established
that the FLAG- or GFP-labeled constructs perform similarly).
(B) The suppression of CD45 and CD3 by I spectrin peptides is substantial, as measured by the fraction of cells expressing on their surface
more than the median level expressed by control cells.
(C) The suppression of surface display is not due to a suppression of CD45 synthesis or to accelerated degradation or shedding, since total
cellular levels of CD45 remain constant (n  3 independent determinations, 2SD).
evaluated by FACS analysis (Figure 4). Another protein tein, CD43, was unaffected by any of the spectrin pep-
tides. Thus, the spectrin-dependent suppression of re-that responded in a manner analogous to CD45 was
CD3, a component of the TCR complex that may also ceptor display was specific for both the isoform of
spectrin involved and the subset of lymphocyte recep-interact with CD45 (Leitenberg et al., 2001). The surface
level of CD3 was reduced by over a log in cells express- tors affected.
Finally, the spectrin-expressing Jurkat cell lines wereing IN-5 or I14-15 spectrin but not in cells carrying IN-5,15.
Conversely, a different lymphocyte membrane glycopro- evaluated for their ability to be activated, as measured
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Table 1. Stimulation of IL2 Generation by Jurkat T Cells (pg/ml/105 Cells)
Stimulus\Cell Line No Stimulation PMA Ionomycin CD3 CD28 CD28 PMA Ionomycin
vector 46.9  0.4 1811.4  313.3 75.1  0.9 3773.2  283.5
IN–5 45.7  1.2 102.8  5.5 47.0  0.4 221.6  31.9
I14–15 45.8  0.6 78.0  2.9 46.3  0.9 161.8  31.6
IN–5,15 49.1  1.2 1029.8  404.6 99.3  6.4 3828.1  347.9
Mean  standard error of the mean; n  3 for each determination.
by IL2 secretion (Table 1). There were no differences in 16.4  27.7 and 14.4  18.3 hr, respectively), although
given the variability intrinsic to these measurements,the resting levels of IL2 between any of the cell lines or
in the vector alone controls. Conversely, and regardless these differences did not achieve significance. It should
also be noted that the CD45 surface lifetime in Jurkatof the method of stimulation, cell lines expressing either
IN-5 orI14-15 demonstrated markedly diminished respon- cells is comparable to its overall half-life in a T cell
hybridoma line of 8–9 hr (Minami et al., 1991). We there-siveness. This blockage was absolute (100%) when cells
were stimulated by methods that depend on receptor fore conclude that the impact of the IN-5 and IN-5,15
peptides is to impair the delivery of an intracellular poolengagement (e.g., anti-CD3 and anti-CD28), consistent
with the reductions in surface CD45 and CD3. However, of CD45 to the membrane, rather than to destabilize
CD45 once it reaches the PM.an unexpected result was the almost complete block
observed when cells were stimulated by pathways that
act downstream of CD45 and CD3, such as via phorbol The Cytoplasmic Domain of CD45 Binds Ankyrin
with High Affinityester (PMA) and ionomycin  CD28 (an accessory re-
ceptor augmenting T cell stimulation, Michel et al., 2001). While CD45 has previously been demonstrated to bind
directly to spectrin (Lokeshwar and Bourguignon, 1992),While independent observations have noted that even
the PMA activation pathway in lymphocytes is sup- it seemed unlikely that this interaction was playing a
role in the dominant suppressive effects of the IN-5 andpressed by the loss of CD45 (Czyzyk et al., 1998; Kishi-
hara et al., 1993), levels of suppression in excess of 60% I15,15 peptides, given that these peptides share no com-
mon sequence that might harbor a CD45 binding site.are difficult to attribute to the loss of CD45 alone. While
it is likely that suppression of other surface receptors Conversely, both peptides would compete for spectrin-
and ankyrin-mediated linkages between CD45 and thethat may also be affected by the spectrin peptides might
account for some of this unusual potency, it seems likely cortical actin skeleton or with the motors of microtubule-
based transport. We therefore sought evidence thatthat the inhibitory I spectrin peptides must also exert
a dominant-negative effect on signaling processes CD45 interacted directly with ankyrin. In PBLs and in
Jurkat cells, ankyrin was precipitated by antibodies todownstream of the early T cell receptor signaling defect
normally associated with a pure CD45 deficiency. These CD45 even more so than by antibodies to spectrin. We
therefore undertook to determine whether the cyto-data thus reveal that transfected spectrin peptides are
a novel and potent suppressor of lymphocyte activation plasmic domain of CD45 (cd-CD45) bound to ankyrin
directly. Measured by surface plasmon resonance (Fig-that appear to act at more than one step along the signal
transduction pathway. ure 6), cd-CD45 bound ankyrin with high affinity (Kd 
4.3 3.0 nM). Control experiments carried out with BSA
demonstrated no affinity for cd-CD45.Stability of CD45 at the Membrane Is Unaffected
by I Spectrin Peptides
Given that total cellular CD45 is unchanged with any Discussion
of the spectrin peptides, significant alterations in its
synthesis, degradation, or surface shedding can be ex- The results presented here demonstrate that I spectrin,
previously thought not to be present in lymphocytes, iscluded. It was therefore of interest to determine whether
spectrin peptides were blocking the delivery of CD45 to in fact required for the efficient delivery of CD45 and
CD3 to the lymphocyte surface, for T cell activation, andthe surface or enhancing the rates of CD45 internaliza-
tion and/or recycling. In studies of -Na,K-ATPase traf- we postulate for the maintenance of CD45-rich microdo-
mains on the lymphocyte surface. The mechanism officking, IN-5 was able to block transport early in the
secretory pathway in MDCK cells (Devarajan et al., this requirement involves an ankyrin-mediated linkage
between CD45 and spectrin. Although not directly dem-1997). While we cannot rigorously exclude action at a
pre-Golgi step, since our anti-CD45 antibodies do not onstrated, it is presumed that I spectrin links a CD45-
ankyrin membrane complex to either the actin skeletondetect incompletely glycosylated forms of CD45, we
consider this unlikely given that the total levels of mature or to microtubule-based motility pathways, or both.
These conclusions are supported by several lines ofCD45 are unaffected by any of the peptides (Figure 4).
We therefore measured the lifetime of surface CD45 data: (1) PBLs and Jurkat T cells express multiple iso-
forms of spectrin, but I spectrin is most consistentlyusing surface biotinylation (Figure 5). CD45 in cells ex-
pressing either the vector alone or IN-5,15 demonstrated codistributed with CD45 in cytoplasmic aggregates and
in surface polarized membrane patches and blebs; (2)similar half-lives (6.74.7 and 5.24.2 hr, respectively).
Jurkat cells with theIN-5 and I14-15 transfectants demon- Nonoverlapping I spectrin peptides, representing ei-
ther spectrin’s ankyrin binding site or its actin/ARP1strated slightly lower rates of CD45 internalization (t1/2 
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Figure 5. The Loss of Surface CD45 Is Not
Due to Accelerated Endocytosis
(Top) To determine if the reduction in surface
CD45 was caused by reduced rates of deliv-
ery versus enhanced rates of internalization,
Jurkat cells expressing the various con-
structs were cooled to 0, surface labeled
with reducible biotin, and warmed to 37 for
periods of time. At each time point, surface
CD45 was determined by incubating the cells
at 0 with reduced glutathione to liberate sur-
face accessible biotin, followed by precipita-
tion of biotinylated proteins with avidin and
analysis by Western blotting with anti-CD45.
(Bottom) Western blots from one experiment,
demonstrating the increasing resistance of
biotin-CD45 to reduction as it is internalized
over time. These experiments were per-
formed seven times. While there was variabil-
ity between experiments, the trends within
each experiment were clear and consistent.
The results of five experiments with the most
complete data across time are presented. Ag-
gregated data from all experiments, fitted by
nonlinear regression to a simple one-rate ki-
netic model, are represented by the curves.
The fitted half-lives (hr) for surface CD45 from
this analysis were: vector alone, 6.7  4.7 hr;
for IN-5 cells, 16.4  27.7 hr; for I14-15 cells,
14.4  18.3 hr; for IN-5,15 cells, 5.2  4.2 hr.
Note that there was no acceleration, and pos-
sibly even a reduction (albeit not of signifi-
cance), in the internalization rate of surface
CD45 in the presence of the IN-5 and I14-15
spectrin peptides.
binding site, both suppress the surface display of CD45 surface upon activation (Lee et al., 1988), and a similar
cytoplasmic pool of CD45 that is also redistributed withand CD3; (3) Suppression of CD45 is lost when these
two sites are linked in a single peptide; (4) This effect T cell activation (Minami et al., 1991), these results reveal
a novel role for the lymphocyte cytoskeleton in manag-is specific forI spectrin and is not seen withIII spectrin
peptides; (5) Only a subset of lymphocyte receptors are ing surface receptor display, organization, and sig-
naling.suppressed; other surface proteins such as CD43 are
unaffected; (6) Spectrin peptides that suppress CD45/ In other cells, the spectrin-ankyrin skeleton forms a
complex multifunctional lattice that can bind a varietyCD3 lead to a near total loss of Jurkat T cell activation;
(7) Spectrin peptides do not affect total cellular pools of cytosolic and membrane proteins and acidic phos-
pholipids. Spectrin can also interact with all major cy-of CD45, excluding a direct action on cellular viability
or protein synthesis; (8) The surface lifetime of CD45 is toskeletal filament systems (actin, microtubules, and in-
termediate filaments, and thereby tether organizedunchanged, and possibly even lengthened, in the pres-
ence of suppressive spectrin peptides; and (9) The cyto- protein arrays to the cytoskeleton to form “linked mosa-
ics” (De Matteis and Morrow, 2000). A corollary to thisplasmic domain of CD45 binds directly both in vivo (as
measured by coimmunoprecipitation) and in vitro (sur- concept is the notion that spectrin and ankyrin, together
with other adaptor proteins, may link subsets of trans-face plasmon resonance) to ankyrin with high affinity.
Taken with earlier data demonstrating the presence of port vesicles to microtubule-based motors, and thereby
facilitate the transport of such molecules through thecytoplasmic membrane aggregates involving spectrin
and ankyrin that are rapidly recruited to the lymphocyte secretory or endocytic pathways. This spectrin ankyrin
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Figure 6. The Cytoplasmic Domain of CD45
Directly Binds Ankyrin
(Top) Immunoprecipitation of Jurkat cell ly-
sates with antibodies to CD45, III spectrin,
or AnkG119, followed by Western blotting with
antibodies to ankyrin, suggests a direct in
vivo interaction between CD45 and ankyrin.
This result is consistent with the direct inter-
actions detected in peripheral blood leuko-
cytes (Figure 1).
(Bottom) The cytoplasmic domain of CD45
(cd-CD45) was assayed for its ability to bind
directly to ankyrin, as measured by surface
plasmon resonance. Increasing concentra-
tions of AnkR or BSA were passed over immo-
bilized cd-CD45. Binding constants were deter-
mined by nonlinear regression analysis, fitted
to a bimolecular interaction model. While BSA
demonstrated no affinity for cd-CD45, an-
kyrin bound avidly (Kd  4.3  3.0 nM).
adapter protein tethering system (SAATS) model can clude participation of spectrin and ankyrin in pre-Golgi
steps along the secretory pathway, as suggested in ourexplain the impact of inhibitory spectrin peptides on the
transport of -Na,K-ATPase from the ER to the Golgi earlier work (Devarajan et al., 1997), the accumulation
of fully glycosylated CD45 in the presence of inhibitory(Devarajan et al., 1997), the disruption that such pep-
tides cause to VSV-G transport (Godi et al., 1998), and spectrin peptides indicates that the predominant block-
age in CD45 trafficking must be post-medial Golgi.the retrograde trafficking of axonal vesicles in the squid
axon (Muresan et al., 2001). Other studies demonstrate The second role of the lymphocyte I spectrin-ankyrin
skeleton is to form defined microdomains involvingthat ankyrin is required in thymic, muscle, and nervous
tissue for the proper intracellular sorting of voltage gated CD45 and CD3/TCR (Figure 7C). By tethering these mol-
ecules into discrete clusters at the PM, we hypothesizeion channels, Ca2 ATPase, and the ryanodine (IP3) re-
ceptor (Tuvia et al., 1999; Zhou et al., 1998). that spectrin and ankyrin may prevent their uncontrolled
diffusion into DIG rafts or into other microdomains, suchIn lymphocytes, the organization of macromolecular
microdomains centered around the CD3/TCR complex as those defined by the interaction of CD43 with the actin
skeleton via the adaptor protein moesin (Allenspach ethas emerged as a central and crucial theme in the control
of T cell signaling (Leitenberg et al., 2001). Factors driv- al., 2001; Delon et al., 2001). With lymphocyte activation,
we anticipate that CD3/TCR is released from the spec-ing the organization and distribution of these complexes
include interactions between the receptors themselves trin-ankyrin and CD45 complex, allowing its putative
redistribution into DIG rafts (Figure 7D). Because theand with costimulatory molecules such as CD45 and
CD4, interactions with the actin cytoskeleton as con- CD3/TCR dynamically associates with DIG rafts (Leiten-
berg et al., 2001), and because CD3 exposes only a verytrolled by several kinases or small G-proteins (Bunnell
et al., 2001; Yu et al., 2001), and differential partitioning short peptide sequence to the cytoplasm, we postulate
that the interaction of the CD3/TCR with spectrin andinto glycolipid-rich lipid microdomains (DIGs) (Balamuth
et al., 2001; Ishii et al., 2001; Janes et al., 2000). We ankyrin is indirect, probably mediated by CD45. Spectrin
I peptides that abrogate the ankyrin-mediated interac-suggest that an additional factor controlling CD45 and
CD3/TCR organization is the spectrin and ankyrin skele- tion of CD45 with spectrin, either by creating transport
complexes that lack an ankyrin binding domain (e.g.,ton. We envision two similar but distinct roles for the I
spectrin-ankyrin lymphocyte skeleton. The first is its IN-5) or by directly saturating the spectrin binding do-
main on ankyrin (e.g., I14-15), dominantly suppress spec-putative role in clustering, and presumably stabilizing,
the perinuclear spectrin and CD45-rich lymphocyte ag- trin-mediated associations with the filamentous skele-
ton and the motors of transport (Figure 7E) and disruptgregates (Figure 7A). Spectrin is proposed to link CD45-
and CD3/TCR-rich trafficking vesicles emerging from spectrin-ankyrin microdomains (Figure 7F).
Finally, it must be recognized that the interaction ofthe TGN or from late endosomal recycling compart-
ments into a receptor-rich reservoir poised for recruit- spectrin and ankyrin with the lymphocyte membrane is
obviously more complex than outlined in Figure 7. Onement to the PM. Spectrin and ankyrin tether this cargo
to microtubule-based motors for transport to the PM surprising result of these studies is the spectrin-depen-
dent inhibition of even receptor-independent activation(Figure 7B). These motors may be either dynein-dynactin
(for minus-end directed transport, Holleran et al., 1996) pathways (Table 1). We believe that this effect derives
from the involvement of spectrin not only in mediatingor a member of the kinesin family (for plus-end directed
transport, Takeda et al., 2000). Although we cannot ex- the surface presentation of CD45 and CD3 but also from
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Figure 7. Hypothetical Model of How Spectrin and Ankyrin May Modulate CD45 Organization
(A) Vesicles exiting the trans-Golgi network (TGN) or recycled from late endosomal compartments are clustered by spectrin and ankyrin in
the TGN region.
(B) Spectrin tethers CD45- and CD3/TCR-containing transport vesicles to motors of active transport (dynein-dynactin or kinesin family members)
for transport to the PM along microtubules.
(C) At the lymphocyte membrane, spectrin and ankyrin organize CD45 and CD3/TCR into membrane microdomains. These domains are
tethered to the cortical actin skeleton via spectrin. Other proteins such as CD43 do not participate in these interactions. These domains are
distinct from detergent insoluble glycolipid rafts (DIG) that may harbor other costimulatory molecules.
(D) With activation, there is release of CD3/TCR from the spectrin-ankyrin and CD45 microdomain, with concomitant association with DIG
rafts (and other costimulatory molecules).
(E) Inhibitory I spectrin peptides block CD45 and CD3/TCR trafficking by competitively displacing the CD45- and CD3/TCR-containing vessels
from the motors of microtubule transport.
(F) At the PM, the inhibitory spectrin peptides disrupt the organization of the spectrin-ankyrin microdomain, leading to abrogation of this
domain. Spectrin peptides may also disrupt the organization of PKC (not shown), adding to its profound inhibitory effects on T cell activation.
its established role in mediating the compartmentaliza- modifies the distribution and display of CD45 and CD3.
In preliminary studies, we have noted that additionaltion of PKC in activated lymphocytes (Gregorio et al.,
1992, 1994). There is a tight association of PKC with a surface molecules beyond CD45 and CD3 are affected
by I spectrin peptides, although many proteins (suchparticulate spectrin and ankyrin complex after T cell
activation. While not directly studied, we anticipate that as CD43) are not. Whether different spectrins and anky-
rins are needed to organize other receptors, or con-the inhibitory  spectrin peptides reported here will also
decouple the association of PKC from this particulate versely whether a given receptor is associated with dif-
ferent spectrins and ankyrins depending on its locationcomplex and thereby possibly disrupt its activity. In fu-
ture studies, it will thus be interesting to evaluate in the cell, remain questions for future study. Earlier work
has also reported a direct interaction between CD45whether the selective abrogation of spectrin’s PKC bind-
ing activity can suppress downstream activation events and spectrin, presumably II spectrin (Lokeshwar and
Bourguignon, 1992). We do not know if II spectrin,without disturbing surface CD45 or CD3 levels. We also
do not understand why only the I isoform of spectrin which is widely distributed on the PM, plays a role in
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1 hr at room temperature. Slides were viewed using an Olympusthe delivery or stabilization of CD45. However, since the
AX-70 or an IX-70 confocal microscope. Volume deconvolution wasphosphatase activity of CD45 can be regulated by its
performed on images collected at 0.5 or 1.0 m Z-intervals withinteraction with spectrin (Lokeshwar and Bourguignon,
Openlab (Improvision, Inc.).
1992), and since all spectrins will coprecipitate with
CD45 to some degree (Figure 1), it seems likely that IL-2 Secretion Assays
spectrin (and ankyrin) will have many roles in the lym- Cells (105 ) were maintained 48 hr in G418 free medium prior to
assay, then stimulated for 24 hr with: 80 nM PMA, 2 M ionomycin;phocyte beyond those explored here. The present re-
1 g/ml anti-CD3 and anti-CD28; or 1 g/ml anti-CD28, 80 nM PMA,sults nevertheless clearly establish the central impor-
2 M ionomycin. Cell supernatants were assayed for IL-2 by ELISAtance of spectrin and ankyrin for the establishment and
kit (Pierce-Endogen). All determinations were done at least three
maintenance of CD45 and CD3 receptor domains in T times and the results averaged.
lymphocytes, and a role for spectrin-ankyrin in mediat-
ing the signal transduction events central to lymphocyte Immunoprecipitation
Lysates were prepared in RIPA lysis buffer (50 mM Tris [pH 8.0],activation.
150 mM NaCl, 1% NP-40, and 0.5% desoxycholate) at 4, precleared,
incubated overnight with antibodies, and precipitated 1 hr at 4 withExperimental Procedures
Protein A-Sepharose.
Preparation of Spectrin Constructs and Transfected Cell Lines
Surface BiotinylationI spectrin peptides were expressed from existing I spectrin con-
Cells (2 	 106/ml in PBS) were incubated with 25 g/ml NHS-S-structs (Devarajan et al., 1997). Stable Jurkat lines were established
biotin (Pierce) for 15 to 30 min on ice. Biotinylation was quenchedby limiting dilution in G418 after transfection using DMRIE-C
in 10 mM Tris (pH 7.4), 140 mM NaCl. After timed incubations at 37,(GIBCO-BRL). In brief, 6 l of DMRIE-C, 1.0 ml OPTI-MEM I, and
surface accessible biotin was reduced by glutathione. Biotinylated2–4 g DNA was incubated at room temperature for 45 min. Cells
species remaining in RIPA lysates were bound to streptavidin beads,(106 ) were added in 0.2 ml serum free medium and incubated at 37
separated by SDS-PAGE, and CD45 detected by immunoblotting.for 4 hr, after which 2 ml RPMI with 15% FBS and 50 ng/ml PMA
Because surface levels of CD45 in the IN-5 and I14-15 transfectedwas added. Selection in G418 (1.5 mg/ml) was initiated after 24 hr.
lines were reduced, biotin incubation times and the exposure timesAt 48 hr, cells were diluted into 96-well plates and grown in RPMI
for these samples were lengthened to compensate for their reducedand 10% FBS containing 1.5 mg/ml G418.
signal intensity.
RT-PCR Analyses
Surface Plasmon ResonancePrimers specific to I spectrin were used to amplify RNA from either
cd-CD45 (aa 564 to 1268), prepared as a GST fusion protein, wasJurkat cells or human PBLs. A common forward primer in exon 30
a gift from Frank Jirik. GST was removed with thrombin, and the(5
-TGAGAAGTCCACGGCCAGCTGGGCA -3
 or 5
-TGTGCCAGTT
peptide immobilized on a CM5 sensor chip (BIAcore) (Pradhan etCTCGAGGGAT-3
) was used with isoform specific reverse primers
al., 2001). Human erythrocyte ankyrin (AnkR) was in PBS, and Kdto differentiate between spectrin II (5
-GCGGATCCCTAGTAGGG
was calculated by nonlinear least squares fitting to a bimolecularGTGAGAGGG-3
) and spectrin III (5
-GCGGATCCCTACTTCTTT
binding equation using BIAevaluation software 3.0.TTGGG-3
). Spectrin III was amplified using forward primer 5
-ACA
CCACAGACAAGTTCCGCTT-3
 and reverse primer 5
-AGCGTTTT
AcknowledgmentsTCTCGCTCTCGT-3
. Construct expression was verified by RT-PCR.
For IN-5: forward primer 5
-AGCTGCCACCATGGACTACAAGGAC
We thank Frank Jirik for GST-CD45, Adriana Ada Meszaros for pri-GACGATGACAAGGGACCTA-3
 (with the FLAG epitope sequence),
mary lymphocytes, and Paul Stabach for spectrin constructs. Thisreverse 5
- TTCTGAACAACTTCCCGCTC -3
; for I14-15: forward as
work was supported by grants from the National Institutes of Healthfor IN-5, reverse 5
-GGCATTCACATTGTCCACCCGC-3
; for IN-5,15:
to J.S.M.forward 5
-GGCCCAGGCGGACCTGCGTCAG -3
, reverse 5
-GGC
ATTCACATTGTCCACCCGC-3
. III spectrin constructs were gener-
Received: January 2, 2002ated as before (De Matteis and Morrow, 2001). Spectrin IIIN-5 in-
Revised: August 9, 2002cluded codons 1–851; III14-15 codons 1696–1906; IIIN-5,15 was a chi-
mera of these two.
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